Achieve Life Sciences Inc.

6.95+0.1200+1.76%Vol 23.46K1Y Perf -31.84%
May 18th, 2022 16:00 DELAYED
BID6.50 ASK7.38
Open6.98 Previous Close6.83
Pre-Market- After-Market-
 - -  - -%
Target Price
37.00 
Analyst Rating
Strong Buy 1.00
Potential %
432.37 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★ —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
27.82 
Earnings Rating
Buy
Market Cap67.28M 
Earnings Date
12th May 2022
Alpha-0.06 Standard Deviation0.25
Beta1.14 

Today's Price Range

6.777.00

52W Range

5.6210.40

5 Year PE Ratio Range

-1.10-0.4000

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
8.07%
1 Month
-11.87%
3 Months
-10.95%
6 Months
-9.05%
1 Year
-31.84%
3 Years
-90.21%
5 Years
-99.11%
10 Years
-99.98%

TickerPriceChg.Chg.%
ACHV6.950.12001.76
AAPL140.82-8.4200-5.64
GOOG2 248.02-86.0100-3.69
MSFT254.08-12.1200-4.55
XOM90.65-1.4600-1.59
WFC42.11-1.6000-3.66
JNJ175.50-3.3200-1.86
FB192.24-10.3800-5.12
GE75.20-1.2000-1.57
JPM120.09-2.0900-1.71
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.82-0.802.44
Q04 2021-0.73-0.76-4.11
Q03 2021-1.09-0.7134.86
Q02 2021-1.23-1.53-24.39
Q01 2021-0.78-1.30-66.67
Q04 2020-1.27-1.1112.60
Q03 2020-1.30-1.1412.31
Q02 2020-3.80-1.6855.79
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.770.00-
9/2022 QR-0.7317.98Positive
12/2022 FY-3.12-13.04Negative
12/2023 FY-2.2410.04Positive
Next Report Date-
Estimated EPS Next Report-0.82
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume23.46K
Shares Outstanding9.68K
Shares Float9.66M
Trades Count327
Dollar Volume162.23K
Avg. Volume104.21K
Avg. Weekly Volume41.99K
Avg. Monthly Volume179.90K
Avg. Quarterly Volume90.75K

Achieve Life Sciences Inc. (NASDAQ: ACHV) stock closed at 6.83 per share at the end of the most recent trading day (a 0.59% change compared to the prior day closing price) with a volume of 25.59K shares and market capitalization of 67.28M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 14 people. Achieve Life Sciences Inc. CEO is John Bencich.

The one-year performance of Achieve Life Sciences Inc. stock is -31.84%, while year-to-date (YTD) performance is -12.21%. ACHV stock has a five-year performance of -99.11%. Its 52-week range is between 5.6205 and 10.4, which gives ACHV stock a 52-week price range ratio of 27.82%

Achieve Life Sciences Inc. currently has a PE ratio of -1.60, a price-to-book (PB) ratio of 2.24, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -77.98%, a ROC of -82.42% and a ROE of -105.66%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Achieve Life Sciences Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.82 for the next earnings report. Achieve Life Sciences Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Achieve Life Sciences Inc. is Strong Buy (1), with a target price of $37, which is +432.37% compared to the current price. The earnings rating for Achieve Life Sciences Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Achieve Life Sciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Achieve Life Sciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 22.10, ATR14 : 0.47, CCI20 : -54.05, Chaikin Money Flow : 0.35, MACD : -0.20, Money Flow Index : 62.81, ROC : -1.44, RSI : 44.65, STOCH (14,3) : 46.32, STOCH RSI : 1.00, UO : 37.99, Williams %R : -53.68), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Achieve Life Sciences Inc. in the last 12-months were: Anthony Clarke (Option Excercise at a value of $0), Cindy Jacobs (Option Excercise at a value of $0), Jerry Wan (Option Excercise at a value of $0), John Bencich (Option Excercise at a value of $0), Richard Alistair Balfour Stewart (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (100.00 %)
5 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline.

CEO: John Bencich

Telephone: +1 425 686-1500

Address: 520 Pike Street, Seattle 98101, WA, US

Number of employees: 14

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

60%40%

Bearish Bullish

58%42%

Bearish Bullish

59%41%

TipRanks News for ACHV

News

Stocktwits